These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37584311)

  • 1. Association of periodontitis with cognitive decline and its progression: Contribution of blood-based biomarkers of Alzheimer's disease to this relationship.
    Carballo Á; López-Dequidt I; Custodia A; Botelho J; Aramburu-Núñez M; Machado V; Pías-Peleteiro JM; Ouro A; Romaus-Sanjurjo D; Vázquez-Vázquez L; Jiménez-Martín I; Aguiar P; Rodríguez-Yáñez M; Aldrey JM; Blanco J; Castillo J; Sobrino T; Leira Y
    J Clin Periodontol; 2023 Nov; 50(11):1444-1454. PubMed ID: 37584311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
    van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
    J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injury markers predict time to dementia in subjects with MCI and amyloid pathology.
    van Rossum IA; Vos SJ; Burns L; Knol DL; Scheltens P; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; L'italien G; van der Flier WM; Teunissen CE; Blennow K; Barkhof F; Rueckert D; Wolz R; Verhey F; Visser PJ
    Neurology; 2012 Oct; 79(17):1809-16. PubMed ID: 23019259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.
    Abdelnour C; van Steenoven I; Londos E; Blanc F; Auestad B; Kramberger MG; Zetterberg H; Mollenhauer B; Boada M; Aarsland D;
    Mov Disord; 2016 Aug; 31(8):1203-8. PubMed ID: 27296778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol metabolites and plant sterols in cerebrospinal fluid are associated with Alzheimer's cerebral pathology and clinical disease progression.
    Jahn T; Clark C; Kerksiek A; Lewczuk P; Lütjohann D; Popp J
    J Steroid Biochem Mol Biol; 2021 Jan; 205():105785. PubMed ID: 33171206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of aβ1-40, aβ1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment.
    Parnetti L; Chiasserini D; Eusebi P; Giannandrea D; Bellomo G; De Carlo C; Padiglioni C; Mastrocola S; Lisetti V; Calabresi P
    J Alzheimers Dis; 2012; 29(1):229-38. PubMed ID: 22232006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Utility of Plasma Amyloid and Tau for Cognitive Decline in Cognitively Normal Adults.
    Lee YJ; Lin SY; Peng SW; Lin YC; Chen TB; Wang PN; Cheng IH
    J Prev Alzheimers Dis; 2023; 10(2):178-185. PubMed ID: 36946444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment.
    Garrett SL; McDaniel D; Obideen M; Trammell AR; Shaw LM; Goldstein FC; Hajjar I
    JAMA Netw Open; 2019 Dec; 2(12):e1917363. PubMed ID: 31834392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of amyloid/tau/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer's disease.
    Delmotte K; Schaeverbeke J; Poesen K; Vandenberghe R
    Alzheimers Res Ther; 2021 Apr; 13(1):84. PubMed ID: 33879243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study.
    Hanon O; Vidal JS; Lehmann S; Bombois S; Allinquant B; Baret-Rose C; Tréluyer JM; Abdoul H; Gelé P; Delmaire C; Blanc F; Mangin JF; Buée L; Touchon J; Hugon J; Vellas B; Galbrun E; Benetos A; Berrut G; Paillaud E; Wallon D; Castelnovo G; Volpe-Gillot L; Paccalin M; Robert P; Godefroy O; Camus V; Belmin J; Vandel P; Novella JL; Duron E; Rigaud AS; Schraen-Maschke S; Gabelle A;
    Alzheimers Dement; 2022 Dec; 18(12):2537-2550. PubMed ID: 35187794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in Alzheimer's disease: plasma MMP-9 and markers of disease severity.
    Tsiknia AA; Sundermann EE; Reas ET; Edland SD; Brewer JB; Galasko D; Banks SJ;
    Alzheimers Res Ther; 2022 Nov; 14(1):160. PubMed ID: 36324151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF biomarkers and amyloid PET: concordance and diagnostic accuracy in a MCI cohort.
    Spallazzi M; Barocco F; Michelini G; Immovilli P; Taga A; Morelli N; Ruffini L; Caffarra P
    Acta Neurol Belg; 2019 Sep; 119(3):445-452. PubMed ID: 30847669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indicators of rapid cognitive decline in amnestic mild cognitive impairment: The role of plasma biomarkers using magnetically labeled immunoassays.
    Tsai CL; Liang CS; Yang CP; Lee JT; Ho TH; Su MW; Lin GY; Lin YK; Chu HT; Hsu YW; Yang FC
    J Psychiatr Res; 2020 Oct; 129():66-72. PubMed ID: 32592947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study.
    Oliveira Monteiro MPA; Salheb Oliveira DSM; Manzine PR; Crispim Nascimento CM; Dos Santos Orlandi AA; de Oliveira Gomes GA; Dos Santos Orlandi F; Zazzetta MS; Pott-Junior H; Cominetti MR
    Alzheimers Res Ther; 2021 Jan; 13(1):18. PubMed ID: 33419480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing In-House Cutoffs of CSF Alzheimer's Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort.
    Orellana A; García-González P; Valero S; Montrreal L; de Rojas I; Hernández I; Rosende-Roca M; Vargas L; Tartari JP; Esteban-De Antonio E; Bojaryn U; Narvaiza L; Alarcón-Martín E; Alegret M; Alcolea D; Lleó A; Tárraga L; Pytel V; Cano A; Marquié M; Boada M; Ruiz A
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer's disease-associated biomarkers alterations among de novo Parkinson's disease patients: a prospective cohort study.
    Liu T; Zuo H; Ma D; Song D; Zhao Y; Cheng O
    J Neuroinflammation; 2023 Jul; 20(1):167. PubMed ID: 37475029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between CSF biomarkers of Alzheimer's disease and global cognition in a psychogeriatric clinic cohort.
    Radanovic M; Oshiro CA; Freitas TQ; Talib LL; Forlenza OV
    Braz J Psychiatry; 2019; 41(6):479-484. PubMed ID: 31166546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.